ACGN — Aceragen Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- $3.20m
- $1.08m
- $4.86m
U.S. STOCKS ON THE MOVE-Kiniksa Pharma, Tonix, Construction Partners
Idera Pharma: Slumps on disappointing cancer trial data, brokerage downgrades
U.S. RESEARCH ROUNDUP- Acutus Medical , Columbia Property Trust, Sundial Growers
Idera: Dives after skin cancer therapy trial fails to meet main goal
Brief: Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial Of Tilsotolimod + Ipilimumab In Anti-PD-1 Refractory Advanced Melanoma
Brief: Idera Pharmaceuticals Files For Shelf Of Up To 4.1 Mln Shares By Selling Stockholders
Brief: Idera Pharmaceuticals Posts Q4 Loss Per Share $2.11
Brief: Idera Pharmaceuticals Announces Dan Soland To Join As Chief Operating Officer
Brief: Idera Pharmaceuticals Reports Third Quarter Financial Results And Provides Corporate Update
U.S. STOCKS ON THE MOVE-FedEx, Lithium Americas, Biogen, Merit Medical Systems
U.S. STOCKS ON THE MOVE-Boeing, Bank of America, Eiger BioPharmaceuticals, Pangaea Logistics
Idera Pharma gains on new U.S. patent for cancer drug tilsotolimod
Brief: Idera Pharmaceuticals Announces New U.S. Patent Coverage For Tilsotolimod Through September 2037
Brief: Idera Pharmaceuticals Inc Files For Mixed Shelf Of Up To $150 Million – SEC Filing
Brief: Idera Pharmaceuticals Inc Files For Shelf Of Up To 5.5 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Idera Pharmaceuticals Reports Second Quarter Financial Results
Brief: Idera Pharmaceuticals Announces Private Placement Of Up To $20.0 Mln
Brief: Idera Pharmaceuticals Says On June 9, Howard Pien Notified Co Of His Decision To Take Leave Of Absence From Board For Medical Reasons
U.S. STOCKS ON THE MOVE-Raytheon, Planet Fitness, Lands End